Aug 11, 2026 07:18AM
Aug 11, 2026 07:00AM
May 12, 2026 07:03AM
May 12, 2026 07:01AM
Mar 10, 2026 07:01AM
Nov 14, 2025 06:11AM
Nov 12, 2025 07:01AM Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Nov 4, 2025 07:05AM
Nov 4, 2025 07:05AM
Aug 14, 2025 04:22PM
Aug 14, 2025 07:00AM
May 6, 2025 04:05PM
Apr 29, 2025 04:49AM
Mar 12, 2025 06:20AM Citizens JMP Reiterates Market Outperform Rating on Prelude Therapeutics (PRLD)
Mar 10, 2025 07:30AM
Nov 7, 2024 09:11AM
Nov 6, 2024 04:05PM
Aug 12, 2024 09:05AM
Aug 12, 2024 07:01AM
May 7, 2024 07:51AM
May 7, 2024 07:01AM Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Mar 13, 2024 03:56AM
Feb 16, 2024 03:27AM
Feb 15, 2024 04:05PM
Nov 1, 2023 04:11PM
Nov 1, 2023 04:10PM
Aug 3, 2023 08:00AM
May 8, 2023 09:03AM Prelude Therapeutics Incorporated (PRLD) Tops Q1 EPS by 9c
May 8, 2023 08:30AM
Mar 15, 2023 08:30AM
Mar 15, 2023 08:30AM
Nov 14, 2022 08:00AM
Nov 14, 2022 08:00AM
Aug 9, 2022 08:00AM
May 10, 2022 08:00AM Prelude Therapeutics Announces First Quarter 2022 Financial Results and Operations Update
Mar 16, 2022 07:35AM
Mar 16, 2022 07:30AM
Nov 12, 2021 08:00AM
Aug 12, 2021 07:30AM
May 11, 2021 07:30AM
Mar 16, 2021 08:00AM
Nov 10, 2020 07:30AM Prelude Therapeutics Announces Third Quarter 2020 Financial Results

1,222,633 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All